معرفی
Pierre Buffet is the Medical Director at the Pasteur Institute in Paris, France, where he leads the Medical Direction department. He is a principal investigator on multiple research projects, including RAVIPRES, which studies the antimalarial mechanism of ravidasvir, and other initiatives focused on malaria, leishmaniasis, and health data systems. His work bridges clinical medicine and translational research, with a strong emphasis on parasitology and hematological disorders.
His research interests include parasitology, infectious diseases, malaria, leishmaniasis, translational research, spleen function, and red blood cell disorders. His studies often explore the interplay between host physiology and parasitic infections, particularly how spleen function influences disease outcomes in malaria and sickle cell disease.
The recent publications highlight a strong focus on the role of the spleen in clearing pathogenic erythrocytes, mechanisms of malarial anemia, and diagnostic markers for spleen function. His work combines clinical data analysis with laboratory-based investigations, contributing to a deeper understanding of hematological complications in infectious and genetic blood disorders.
Scientific Awards:
- No scientific awards mentioned in the provided text.
Advising and Grants:
Pierre Buffet is the principal investigator (PI) on several research projects, including RAVIPRES (2024-071), TANGO-LeisH, studies using the National Health Data System (SNDS), and the Translational Research Day. He leads initiatives to promote MD-PhD physician-researcher careers and organizes academic events such as the Quart d’heure Pasteur Médecine. These roles indicate active grant leadership and mentorship in clinical and translational research.
Labs and Teams:
He is associated with the Medical Direction at the Pasteur Institute and collaborates with teams in parasitology and hematology. He is involved in the Biology of Host-Parasite Interactions network and participates in cross-functional projects related to mother-child health and vaccine hesitancy.
